The Effect of Vitamin D Supplementation on Plasma Aβ in an Older Population: A Randomized Control Trial
Explore this paper's citation graph
- Type
- dissertation
- Published
- 2015-01-01
- Cited by
- 0
- References
- 151
- OpenAlex
- https://openalex.org/W2611666387
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:79644912
Keywords
Randomized controlled trial, Population, Medicine, Internal medicine, Environmental health
References
- Intraneuronal amyloid‐β1‐42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death
- Vitamin D deficiency in the Southern United States.
- Therapeutic Albumin Binding to Remove Amyloid-β
- The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
- Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer
- Economic analysis of opportunities to accelerate Alzheimer’s disease research and development
- Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study
- Cholinesterase inhibitors for mild cognitive impairment.
- Vitamin D insufficiency and mild cognitive impairment: cross‐sectional association
- A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer’s Disease
- Validation of a Multiplex Assay for Simultaneous Quantification of Amyloid-β Peptide Species in Human Plasma with Utility for Measurements in Studies of Alzheimer's Disease Therapeutics
- Neuronal calcium signaling, mitochondrial dysfunction and Alzheimer’s disease
- A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
- Enhanced Brain Amyloid-β Clearance by Rifampicin and Caffeine as a Possible Protective Mechanism Against Alzheimer’s Disease
- Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies
- Genomic and Nongenomic Signaling Induced by 1α,25(OH)2-Vitamin D3 Promotes the Recovery of Amyloid-β Phagocytosis by Alzheimer's Disease Macrophages
- Decreased Clearance of CNS Amyloid-β in Alzheimer’s Disease
- Peripheral Amyloid-β Levels Regulate Amyloid-β Clearance from the Central Nervous System
- Amyloid-β and Mitochondria in Aging and Alzheimer’s Disease: Implications for Synaptic Damage and Cognitive Decline
- A Randomized, Controlled Trial of Doxycycline and Rifampin for Patients with Alzheimer's Disease
Cited by
No citing papers recorded for this paper.
Related papers
- Vitamin D deficiency is associated with increased risk of Alzheimer’s disease and dementia: evidence from meta-analysis
- [Could intake of vitamins C and E inhibit development of Alzheimer dementia?].
- Vitamin D and cardiovascular prevention
- Does vitamin D supplementation in elderly adults improve cognitive outcomes
- Efficacy of Vitamin B Supplementation on Cognition in Elderly Patients With Cognitive-Related Diseases
- B-vitamins reduce plasma levels of beta amyloid.